Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of Topiramate on Dysaesthetic Pain in a Patient with Multiple Sclerosis.
Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Selective JAK1 inhibitor and selective Tyk2 inhibitor patents.
Immune activation, viral gene product expression and neurotoxicity in the HIV-1 transgenic rat.
Fatigue and Depression in Children With Demyelinating Disorders.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Self-reported Depression and Physical Activity in Adults with Mobility Impairments.
Ion Channel Modulation as a Therapeutic Approach in Multiple Sclerosis.
Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.
Please mind the gap: axonal transport deficits in multiple sclerosis neurodegeneration.
Major stressful life events in adulthood and risk of multiple sclerosis.
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial.
Naltrexone prescribing information
Differential diagnosis for cervical spondylotic myelopathy: literature review.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Harnessing monocyte-derived macrophages to control central nervous system pathologies: No longer 'if' but 'how'
Macrophage and NK-mediated killing of precursor-B acute lymphoblastic leukemia cells targeted with a-fucosylated anti-CD19 humanized antibodies.
Navigating Life and Loss in Pediatric Multiple Sclerosis.
Management of multiple sclerosis: An overview.
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.
Redox regulation of NF-κB p50 and M1 polarization in microglia.
[American Academy of Neurology, Washington, 18-25 April 2015].
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »